Featuring Laurence W. Zeifman, Patrick Trucchio, Juan Cappello, Yeji Jesse Lee, Edward Zhong.
Psychedelic companies have been getting large valuations very quickly. With ATAI at a 2.27B market cap, Compass Pathways at 1.46B, and GHRS 691M many people are left wondering how realistic these numbers are. By talking to experts on all sides of the story: sell-side research analyst, independent financial consultant, and buy-side investment analyst, we should be able to gain more understanding of what these valuations mean, how they are calculated, and what makes a company in the psychedelic space potentially attractive investment.
3:30 pm
Nov 8
Featuring Laurence W. Zeifman, Patrick Trucchio, Juan Cappello, Yeji Jesse Lee, Edward Zhong.
Psychedelic companies have been getting large valuations very quickly. With ATAI at a 2.27B market cap, Compass Pathways at 1.46B, and GHRS 691M many people are left wondering how realistic these numbers are. By talking to experts on all sides of the story: sell-side research analyst, independent financial consultant, and buy-side investment analyst, we should be able to gain more understanding of what these valuations mean, how they are calculated, and what makes a company in the psychedelic space potentially attractive investment.